- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events
Playback speed
10 seconds
Ph-like ALL Therapy Should Be Different From the Other B-ALL: Targeted Therapy Consequence w/ TKI Are JAK2 Added to the Relapse Regimen or IO Approach
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Dieter Hoelzer
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Dieter Hoelzer
0 views
December 30, 2019
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology